Omics Lab Services Market Report 2026

Omics Lab Services Market Overview

• Omics Lab Services market size has reached to $109.47 billion in 2025 • Expected to grow to $224.14 billion in 2030 at a compound annual growth rate (CAGR) of 15.4% • Growth Driver: Rising Prevalence Of Genetic Diseases Fueling The Growth Of The Market Due To Advancements In Diagnostic Technologies And Personalized Medicine Needs • Market Trend: Innovative High-Throughput Genomics Platforms Advance Precision Medicine And Disease Research • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Omics Lab Services Market?

Omics lab services refers to an extensive range of laboratory services dedicated to examining the full spectrum of biological molecules within a given biological system. These services are designed to generate a holistic understanding of how these molecular components are organized, regulated, and interact with each other to influence the structure and function of living organisms. The main types of services in omics lab services are genomics, transcriptomics, proteomics, metabolomics, and epigenomics. Genomics is the study of the entire set of DNA (the genome) in an organism, including all of its genes and their functions. These services are offered through various models such as contract services, in-house services, consultative services, collaborative research, and custom solutions and use technologies like next-generation sequencing (NGS), microarray technology, mass spectrometry, chromatography, and bioinformatics tools. It finds applications in drug discovery, diagnostics, personalized medicine, and others, catering to diverse end users including research institutions, pharmaceutical companies, biotechnology firms, academic institutions, and clinical laboratories.

What Is The Omics Lab Services Market Growth Forecast?

The omics lab services market size is expected to see rapid growth in the next few years. It will grow to $224.14 billion in 2030 at a compound annual growth rate (CAGR) of 15.4%. The growth in the forecast period can be attributed to increasing adoption of personalized medicine research, rising investments in systems biology, expansion of ai-enabled bioinformatics tools, growing demand for end-to-end omics solutions, increasing focus on data-driven drug discovery. Major trends in the forecast period include increasing demand for integrated multi-omics analysis, growing adoption of contract research services, expansion of bioinformatics-driven data interpretation, rising use of high-throughput analytical platforms, enhanced focus on translational research support.

Global Omics Lab Services Market Segmentation

1) By Type Of Omics Services: Genomics, Transcriptomics, Proteomics, Metabolomics, Epigenomics 2) By Service Model: Contract Services, In-House Services, Consultative Services, Collaborative Research, Custom Solutions 3) By Technology Platform: Next-Generation Sequencing (NGS), Microarray Technology, Mass Spectrometry, Chromatography, Bioinformatics Tools 4) By Application: Drug Discovery, Diagnostics, Personalized Medicine, Other Applications 5) By End Users: Research Institutions, Pharmaceutical Companies, Biotechnology Firms, Academic Institutions, Clinical Laboratories Subsegments: 1) By Genomics: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing, Single-Cell Genomics, Comparative Genomic Hybridization 2) By Transcriptomics: Messenger Ribonucleic Acid (RNA) Sequencing, Non-Coding Ribonucleic Acid (RNA) Sequencing, Expression Profiling, Ribonucleic Acid (RNA) Microarrays, Single-Cell Transcriptomics 3) By Proteomics: Protein Identification, Protein Quantification, Post-Translational Modifications Analysis, Protein-Protein Interaction Mapping, Structural Proteomics 4) By Metabolomics: Targeted Metabolomics, Untargeted Metabolomics, Lipidomics, Fluxomics, Metabolic Fingerprinting 5) By Epigenomics: Deoxyribonucleic Acid (DNA) Methylation Analysis, Histone Modification Profiling, Chromatin Accessibility Assays, Chromatin Immunoprecipitation Sequencing, Non-Coding Ribonucleic Acid (RNA) Epigenetic Regulation

What Is The Driver Of The Omics Lab Services Market?

The rising prevalence of genetic diseases is expected to propel the growth of the omics lab services market going forward. Genetic diseases are disorders caused by abnormalities or mutations in an individual's DNA, which can be inherited or occur spontaneously. The prevalence of genetic diseases is rising as advancements in diagnostic technologies, particularly next-generation sequencing and other genomic tools, have significantly improved the ability to detect and identify a wide range of genetic disorders that previously went undiagnosed or were misclassified. Omics lab services help in genetic diseases by analyzing complex biological data to identify mutations and molecular changes, enabling early diagnosis and personalized treatment. For instance, in October 2024, according to the Cystic Fibrosis Trust, a UK-based charity dedicated to supporting people with cystic fibrosis, in 2022, 11,148 cystic fibrosis patients were registered, and this number grew to 11,318 in 2023, reflecting a 1.5% increase in patient registrations year-over-year. Therefore, the rising prevalence of genetic diseases is driving the growth of the omics lab services industry.

Key Players In The Global Omics Lab Services Market

Major companies operating in the omics lab services market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Macrogen Inc., MedGenome Labs Ltd., Metabolon Inc., Zymo Research Corporation, CD Genomics, BaseClear B.V., Strand Life Sciences Pvt. Ltd., Sengenics Corporation Pte Ltd., Psomagen Inc., Biocrates Life Sciences AG, Creative Proteomics

Global Omics Lab Services Market Trends and Insights

Major companies in the omics lab services market are focusing on developing innovative solutions such as high-throughput genomics to accelerate biomedical research and precision medicine. High-throughput genomics is the use of advanced technologies to rapidly sequence and analyze large volumes of DNA or RNA, enabling large-scale genetic studies efficiently. For instance, in September 2024, The Translational Genomics Research Institute (TGen), a US-based nonprofit medical research institute, launched the Center for Spatial Multi-Omics (COSMO). The center provides high-resolution whole-transcriptome data using sequencing-based Visium HD, combined with histological staining, and offers tissue processing services such as Tissue Microarray (TMA) construction for cost-effective, multiplexed sample analysis. Its customizable platforms, enhanced by machine learning-driven cell segmentation, allow detailed visualization and mapping of molecular data within intact tissues, supporting advancements in precision medicine and disease research.

What Are Latest Mergers And Acquisitions In The Omics Lab Services Market?

In July 2024, Anacura, a Belgium-based healthcare and life science company, acquired ohmX.bio NV for an undisclosed amount. Through this acquisition, Anacura aims to expand its advanced multi-omics capabilities to accelerate drug discovery and diagnostic development while strengthening its position within the Ghent biotech ecosystem and the broader healthcare and pharmaceutical research markets. ohmX.bio NV is a Belgium-based biotechnology company specializing in genomics, transcriptomics, and epigenomics solutions.

Regional Outlook

North America was the largest region in the omics lab services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Omics Lab Services Market?

The omics lab services market includes revenues earned by entities by providing services such as whole genome sequencing, expression profiling, protein identification, biomarker discovery, and chromatin immunoprecipitation analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Omics Lab Services Market Report 2026?

The omics lab services market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the omics lab services industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.